HT
Heron Therapeuti
🇺🇸XNAS.HRTXUnited StatesHealthcare
$0.32USDup +0.01 (+3.23%)OpenDelayed5:45 PM
Price$0.32+0.01 (+3.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4277461020
- CUSIP
- 00754G102
Company
- Employees
- 128
- Headquarters
- Cary, United States
- Website
- https://www.herontx.com
- CEO
- Mr. Craig Alexander Collard
Market
- Shares outstanding
- 189.9M
- Market cap
- $60.75M
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $58.85M
- EPS LTM
- -$0.18
- P/E LTM
- -2.46
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $151.18M+0.99%up year on year
- Net income
- -$34.05M-3,557.25%down year on year
- Gross margin
- 70.07%-6.09%down year on year
- Free cash flow
- -$12.14M+58.91%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.